JODI TWOMBLY: Open Payments
NPI 1841381522 · HIAWATHA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$587 in 32 payments from 11 companies in 2025. Trend: 2023 $484 · 2024 $685 · 2025 $587
Food & beverage: $587
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $154 |
| Lilly USA, LLC | 3 | $90 |
| Novartis Pharmaceuticals Corporation | 4 | $69 |
| Teva Pharmaceuticals USA, Inc. | 2 | $48 |
| Amgen Inc. | 3 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $46 |
| Viatris Specialty LLC | 3 | $43 |
| Exact Sciences Corporation | 2 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Lundbeck LLC | 1 | $18 |
Products named: MOUNJARO, LEQVIO, QULIPTA, UBRELVY, AUSTEDO XR, JARDIANCE, YUPELRI, VRAYLAR.
Industry payments across KS — which companies pay providers there.
